To our knowledge, the influence of large arterial mechanical properties on the incidence of CV events and overall mortality has never been investigated in patients with moderate CKD. We hypothesized that large artery stiffening and remodeling could be predictors of all-cause mortality and CV events in patients with stages 2 to 5 CKD. To address this question, we took advantage of the prospective arterial ancillary study based on the NephroTest cohort (follow-up of 5 years), in which arterial function was measured with gold standard methods in patients with stages 2 to 5 CKD, including applanation tonometry and high-resolution echotracking system. . This population is a subset of the NephroTest cohort that includes non-end-stage adult patients with CKD from 2 departments of nephrology in the Paris area, as previously described. 18, 19 The full description of the studied population is available in the online-only Data Supplement.
Methods

Design and Patients
Arterial Parameters
All patients were studied in a quiet room with controlled temperature of 22±1°C as described previously. Blood pressure was monitored with an oscillometric method (Colins, BP 8800, Colin Corporation Ayashi, Komaki, Japan).
Aortic stiffness, carotid stiffness, diameter, and intima-media thickness measurements are described in the online-only Data Supplement.
Biological Parameters
We collected blood and urine samples to determine the levels of triglyceride, cholesterol high-density lipoprotein and low-density lipoprotein, and urinary albumin:creatinine ratio (UACR) at baseline. GFR was measured by the renal clearance of 51 Cr-EDTA, as described in the online-only Data Supplement.
Outcomes
CV events during follow-up were systematically recorded and documented at each visit. Coronary heart disease, stroke, peripheral arterial disease (amputation, revascularization for critical ischemia, or surgery for abdominal aortic aneurysm), and heart failure were considered as CV events and were adjudicated by an event committee (M.B., J.P.H., P.B., and C.J.). Patients who were lost for followup in the NephroTest cohort were contacted through their general practitioner or their referent nephrologist (n=3 in center 1, n=12 in center 2). Deaths and their causes were identified by record linkage with the national death registry on December 31, 2010 . The date at first qualifying event was retained as a censor date.
Statistical Analyses
Data are expressed as mean±SD (95% CIs), median, and interquartile range or percentage, as appropriate. Estimate of the overall survival was computed according to the Kaplan-Meier product-limit method, as detailed in the online-only Data Supplement.
Cox proportional hazard models were used for overall survival analyses; multivariate competing risks analyses focusing on the risk of fatal and nonfatal CV events were performed with Fine and Gray models, as detailed in the online-only Data Supplement.
Net reclassification improvement and integrated discrimination improvement (IDI) indices using Cox prediction were determined as detailed in the online-only Data Supplement.
Results
Clinical Characteristics at Baseline
The mean age of the included patients was 59.8 years (14.5 years), and the mean measured glomerular filtration rate (Table S1 in the online-only Data Supplement). Hypertensive and diabetic nephropathies were the main causes of CKD in this cohort, representing 57% of the patients (Table S2) .
Large Artery Stiffness, Arterial Remodeling, and Overall Survival
Fifty-three patients died during the follow-up period (mean duration, 4.67 years [0.85 years]), giving an estimated 5-year overall survival of 87% (84-91%). Vascular variable selection was performed in univariate regression analysis in patients from center 1 for whom all vascular parameters had been measured (Table S3) . Brachial pulse pressure, CF-PWV, carotid pulse pressure, carotid stiffness, and carotid internal diameter were confirmed as being significant predictors of outcome. The outcome of these patients was significantly worse for elevated values of any of these 5 covariates ( Figure  1 and Figure S2 in the online-only Data Supplement). We then confirmed, in univariate analyses in the whole population ( −4 ), separate models including either mGFR or log UACR were considered for the subsequent steps of the analyses. After adjusting for age, systolic blood pressure or brachial pulse pressure, diabetes mellitus, active smoking, history of CV events, mGFR, and log UACR remained significantly associated with the overall survival of these patients (Table 1, models 1 and 2; Table S4 , models 1 and 2, respectively). These 2 Cox models were considered as the backbone of covariates to assess the influence of vascular parameters on outcome.
Among the parameters related directly to large artery stiffness (CF-PWV and carotid stiffness) or indirectly (brachial pulse pressure and carotid pulse pressure), CF-PWV had the strongest association with survival, whether considered as a continuous or as a dichotomized covariate, and was therefore chosen for multivariate survival analyses. When added to model 1, CF-PWV was significantly associated with survival (Table 1, model 3; Table S4 , model 3). Results were similar if the analyses were performed in patients with mGFR > or (Figure 2 and Figure S3 ).
Net reclassification improvement and IDI based on Cox prediction were used to quantify the contribution of CF-PWV for risk assessment. CF-PWV in addition to classic CV ( Table 1 ), estimated with increasing mGFR values and according to the presence or absence of diabetes mellitus, history of CV events, active smoking, or any 2 of those, showed that adding carotid internal diameter to the model increased the ability to identify patients with a worse prognosis ( Figure S4 ).
Large Artery Stiffness, Arterial Remodeling, and Fatal and Nonfatal CV Events
Sixty-nine fatal or nonfatal CV events occurred during the follow-up period (n=29 CV-related deaths and n=40 nonfatal CV events, ie, coronary heart disease, n=23; stroke, n=4; other CV events, n=13), giving a 5-year estimated cumulative incidence of CV events of 16.0% (14.8-17 .1%); 5-year estimated incidence of non-CV-related death of 5.6% (5.2-6.0%).
Brachial and carotid PP, CF-PWV, carotid stiffness, carotid intima-media thickness, and carotid internal diameter were significantly associated with the occurrence of fatal or nonfatal CV events in univariate competing risks analyses (Table S3) . As for the overall survival, the risk of CV events increased as these parameters had increasing values ( Figure 3 and Figure S5 ).
In Fine and Gray, competing risk models including renal and CV risks factors, CF-PWV remained significantly associated 
Cumulative incidence of CV events
Gray's test (CV events): P=0.25
Gray's test (Competing risk): P=0.001 Figure 3 . Cumulative incidence of fatal and nonfatal cardiovascular events according to (A) the levels of carotid to femoral pulse wave velocity (CF-PWV) and (B) carotid internal diameter. The estimated cumulative incidence of fatal or nonfatal cardiovascular events for patients with CF-PWV<12 m/s (black line) was 13% vs 38% for those with CF-PWV>12 m/s (blue line). The estimated cumulative incidence of death unrelated to cardiovascular events (competing risk) for patients with CF-PWV<12 m/s (red line) was 4% vs 11% for those with CF-PWV>12 m/s (green line). B, Estimated cumulative incidence of fatal or nonfatal cardiovascular events for patients with carotid internal diameter <7 mm (black line) was 20% vs 33% for those with carotid internal diameter >7 mm (blue line). The estimated cumulative incidence of death unrelated to cardiovascular events (competing risk) for patients with carotid internal diameter <7 mm (red line) was 4% vs 24% for those with carotid internal diameter >7 mm (green line).
by guest on April 13, 2017 http://hyper.ahajournals.org/ Downloaded from with the occurrence of fatal or nonfatal CV events, together with mGFR and history of CV events (Table 2 and Table S5 ).
Discussion
The major finding of this prospective, longitudinal study was that CF-PWV measurement had the ability to predict the outcome of patients with stages 2 to 5 CKD, both in terms of overall survival and occurrence of fatal or nonfatal CV events, even in multivariate models adjusted for other CV and renal risk factors and by taking into account competing risks. In addition, CF-PWV significantly improves the prediction of the risk in this population. This study also provides important findings regarding the remodeling aspect of the carotid artery, showing that carotid internal diameter, but not intimamedia thickness, was an independent risk factor for all-cause mortality.
We first confirmed that mGFR and proteinuria were significant risk factors for all-cause mortality and for fatal or nonfatal CV events in our cohort, as previously reported in patients with CKD and in the general population. 20 These covariates remained significant predictors of outcome after adjusting for traditional CV risk factors.
Among stiffness parameters, including carotid stiffness, carotid pulse pressure, and brachial pulse pressure, CF-PWV was the strongest predictor of survival in this cohort of patients with CKD. The strength of prediction of CF-PWV for all-cause mortality and fatal and nonfatal CV event was of larger magnitude than that reported in patients with hypertension 21 and in a recent meta-analysis. 16 Indeed, adjusted relative risk for 1 SD (3.14 m/s) was 1.48 in patients with CKD when compared with 1.22 for 1 SD in patients with hypertension 21 and 1.42 in the meta-analysis. 16 The prognostic value of aortic stiffness was at least as strong in patients with CKD as in patients with end-stage renal disease (hazard ratio, 1.22 versus 1.15 for 1 m/s, respectively, using the same calibration). 22 These data illustrate that arterial stiffness is an important predictor of CV events in patients with stages 2 to 5 CKD.
In patients with CKD, increase in arterial stiffness results from various phenomenon including arterial calcification and qualitative alteration of the arterial wall content (elastin fragmentation, calcification), as well as quantitative changes with a decrease in elastin content. [23] [24] [25] These modifications occur progressively during CKD evolution and lead to an increased stiffness, which, as shown in this study, impacts detrimentally on the outcome of patients with CKD. Indeed, increased aortic PWV influences the timing of reflected waves return. Accelerated and reflected waves meet the central arteries during early systole, which amplify aortic and ventricular pressures during early systole and reduce aortic pressure later. As a consequence, an increase in aortic stiffness leads to a rise of the central pulse pressure, which increases afterload and induces left ventricular hypertrophy and vascular damage within the brain and the kidney. 26 All these phenomena are stressed in patients with CKD. 27 In the present study, we showed that aortic stiffness improves the characterization of the risk in patients with CKD. This is of importance because the evaluation of the CV risk is very poor in this population. Pooling individuals with CKD from the atherosclerosis risk in communities and CV health studies, Weiner et al 5 have also shown that the accuracy of the Framingham score for the prediction of cardiac events was very low, predicting only 13.9% and 4.8% (men/women) of the 10-year events. In the present study, it is noteworthy that CF-PWV remained a significant predictor of all-cause mortality in Cox proportional hazard models adjusted on traditional CV and renal risk factors. Interestingly, in Cox proportional hazards model-derived survival curves, a CF-PWV value ≥12 m/s improved the identification of a group of highrisk CKD. In addition, net reclassification improvement and IDI provided evidence for significant reclassification of risk of death with PWV above other risk factors. The percentage of reclassification is comparable to the one previously published in other populations. 28, 29 The results of this study may provide new tools for the estimation of the CV risk in patients with CKD with methods easy to use in clinical practice.
14 In addition, normal values are now established for this parameter. 30 In addition to stiffening, specific large artery remodeling occurs in patients with CKD and is characterized by a thinning and a dilation of the carotid artery. 6 We have recently shown that this maladaptive arterial remodeling had deleterious effects on the kidney because it was associated with higher rate of CKD progression. 31 Interestingly, we showed here that, in addition to kidney injury, large arterial remodeling, in particular the arterial dilation component, might influence the outcome of patients with CKD, irrespective of kidney function. In this study, carotid internal diameter was an independent prognostic factor for all-cause mortality, whereas circumferential wall stress, which integrates diameter, intimamedia thickness, and pressure, was not. Arterial enlargement is a process associated with supposedly normal aging 32 but has also been associated with pathological conditions, such as hypertension in menopausal women, 33 hypertension, 34, 35 CKD, 6 and end-stage renal disease patients. 36 In hypertensive patients, an increase in aortic diameter has been independently associated with target organ damage, such as cardiac hypertrophy. The reason why arterial dilation might predispose to premature death is still poorly understood. Because large vessels are continuously submitted to very high level of mechanical stress, dilatation of the common carotid artery might represent a fragility of the extracellular matrix, which could be because of CKD itself. Indeed, CKD is associated for instance with a low-grade inflammatory state in the circulation and in the arterial wall, which might induce the release of metalloproteinase and change the extracellular matrix properties. It can be hypothesized that arterial enlargement is a reflection of a more generalized disease because we showed that carotid internal diameter was associated with death from non-CV origin but not with fatal or nonfatal CV events in the competing risk models. Dilatation may also be partially driven by genetic susceptibility predisposing to early death under constrained conditions, such as superimposed CKD. Lastly, maladaptive arterial remodeling could also influence the transmission of pulse pressure further into the microcirculation and, as a consequence, enhance target organ damage.
The strengths of this study include its prospective design, the extensive clinical and biological investigations as well as the use of measured GFR, and the number and quality of the studied parameters. Despite its small sample size, these patients experienced a large number of events. However, the number of CV deaths, myocardial infarction, and strokes was too small for these events to be studied separately. Because carotid measurements were only available in 1 center (ie, center 1), we cannot exclude that we lack statistical power to assess the overall prognostic value of carotid stiffness. Despite the standardization of working procedures, including 2 sites may have led to heterogeneity. However, no center effect was seen in the survival analyses. These associations have to be confirmed in larger multicenter studies.
Perspective
Through this study, we have shown that large arterial stiffness was significantly associated with all-cause mortality and the occurrence of CV events and conditioned the outcome of patients with CKD. In addition, aortic stiffness improves the prediction of the risk in patients with CKD. These findings should lead us to consider their measurements in a routine clinical procedure to more precisely assess the CV risk in these patients and to improve their outcome.
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What Is New?
• This is the first demonstration in a longitudinal prospective cohort that large artery stiffening impacts the general prognosis and the risk in chronic kidney disease stages 2 to 5 not yet in dialysis. More precisely, aortic stiffness improves the prediction of the risk. In addition, large artery remodeling, more precisely arterial enlargement, was associated with higher rate of all-cause of deaths.
What Is Relevant?
• It is well established that equations traditionally used to estimate CV risk, such as the Framingham equation, perform poorly in patients with chronic kidney disease. In the present study, we showed that aortic stiffness improves the ability to identify patients at high risk of mortality independent of traditional CV risk factor. This study provides basis for the design of interventional trial aiming to reduce aortic stiffness and to improve the prognosis of this population.
Summary
• In the present study, we have shown that large artery stiffening and remodeling have a predictive value for all-cause mortality and fatal and nonfatal CV events in patients with moderate-to-severe chronic kidney disease. More precisely, aortic stiffness improves the prediction of the mortality risk above classic CV and renal risk factor in patients with chronic kidney disease. 2 ). This population is a subset of the NephroTest cohort that includes non end-stage adult CKD patients from two departments of nephrology in the Paris area, as previously described. The 439 included patients underwent a yearly evaluation including medical interview, clinical examination, blood samples, measurement of GFR (mGFR) directly through 51 Cr-EDTA urinary clearance, and measurements of arterial parameters. CV risk factors and previous CV events were collected at the first visit. Aortic stiffness measurements were done in the 439 included patients (centre 1 and 2). Carotid evaluations were done in only one centre (centre 1) in 180 patients. The protocol was approved by St Germain-en-Laye Hospital ethic committee, and all patients gave written informed consent. Arterial parameters Aortic stiffness was estimated by the CF-PWV measured along the descending thoracoabdominal aorta by the validated foot-to-foot velocity method (Complior, ALAM medical, Pantin, France). 1 Briefly, pressure waveforms were obtained at the right common carotid artery and the right femoral artery with a mechanotransducer. The transit time was measured between the feet of the two waveforms. The distance was measured between the two recorded sites (carotid-femoral (CF)). CF-PWV was calculated as CF distance (m) / transit time (s). Common carotid artery pressure waveforms were recorded non-invasively by aplanation tonometry (Sphygmocor ® , Atcor Medical, Sydney, Australia) 2 and local carotid artery pulse pressure (cPP) was used for further calculations. End-diastolic internal diameter, stroke change in diameter, and IMT were measured on the right common carotid artery with high precision echotracking system (Wall Track System ® , Esaote, Maastricht, The Netherlands), as previously described and validated. Carotid distensibility was determined from systolic-diastolic variations in arterial cross-sectional area (ΔA) and local pulse pressure (ΔP) as described earlier, 4 assuming the lumen to be circular. Cross-sectional distensibility coefficient (DC) was calculated as ΔA/AΔP. Carotid stiffness was calculated as (DC) -1/2 . Glomerular filtration rate measurements GFR was measured by the renal clearance of 51 Cr-EDTA, as described in the supplementary files. Briefly, 1.8 to 3.5 MBq of 51 Cr-EDTA (GE Healthcare, Velizy, France) was injected intravenously as a single bolus. After allowing 1 hour for distribution of the tracer in the extracellular fluid, average renal 51 Cr-EDTA clearance was determined on five to six consecutive 30-minute clearance periods. 6 
Statistical analyses
Data are expressed as mean ± standard deviation (SD), median and interquartile (IQ) range or percentage. Estimate of the overall survival was computed according to the Kaplan-Meier product-limit method. Groups were compared using the 2-tailed log-rank test. P-spline method and penalized Cox model were used to define the most appropriate cut-off value(s) for continuous covariates ( Figure S1 in Supplementary file). Cumulative incidences were used to estimate the incidence of CV events, either fatal or not (composite event), all causes of death not related to a CV event being considered as the competing risk factor. The Gray test was used to compare cumulative incidences between groups.
The following covariates were analyzed in univariate analysis: center, gender, body mass index, smoking, diabetes mellitus, dyslipidemia, hypertension, history of CV event, measured glomerular filtration rate, urinary albumin creatinine ratio (LogUACR, Log-transformed values), brachial pulse pressure, carotid femoral pulse wave velocity, carotid pulse pressure, carotid stiffness, carotid internal diameter, carotid intima-media thickness, and carotid circumferential wall stress. A multistep process was considered for Cox models analysing the overall survival. First renal parameters were introduced in the model. Subsequently, usual cardiovascular risk factors were added and a stepwise selection procedure was used to keep in this model cardiovascular covariates that remained significantly associated with the overall survival (p-value threshold, p < 0.05). The covariates of interest, i.e., brachial pulse pressure, CF-PWV and carotid internal diameter were finally added, which led to assess their influence on the overall survival after adjusting for the most significant renal and cardiovascular covariates identified in the previous steps. At each step, collinearity of the covariates as well as interactions between those remaining in the model were tested. Interactions between the significant covariates were tested adding cross-product terms to the model. Expected individual survival curves were produced using the results of the selected Cox proportional hazards models as a rate table, the hypothetical patient being specified in terms of covariates. This hypothetical patient, considered as an example in Figures 2, S3 and S4, was 55 years of age, with a MBP at 110 mmHg, a measured glomerular filtration rate of 20/40/60 ml/min, and either one or two of the following comorbidities: diabetes mellitus, history of CV event, or active smoking. 8 For multivariate competing risks analyses focusing on the risk of fatal and non fatal CV events, the same covariates introduced in the final Cox proportional hazards models were similarly introduced in Fine and Gray models. Net reclassification improvement (NRI) and integrated reclassification improvement (IDI) were performed using the package "survIDINRI' from Harvard Medical school (http://cran.rproject.org/web/packages/survIDINRI/index.html). NRI and IDI were performed including as covariates age, history of CV events, diabetes, SBP, DBP, GFR, LogUACR, and CF-PWV. S-Plus ® 8.0 for Windows Entreprise Developer (Insightful Corporation, Seattle,WA) and Rproject for statistical computing, version 2.15.1 were used for statistical analyses (http://www.r-project.org/).
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Froissart M, Rossert J, Jacquot C, Paillard M, Houillier P. LogUACR, logarithm of albumin to creatinine ratio; SBP, systolic blood pressure; CF-PWV, carotid-femoral pulse wave velocity * models based on the overall group of patients; † model based on the patients followed at Centre 1 Figure S1 . Identification of prognostic thresholds (vertical lines on each graph) for each vascular parameter according to the evolution of the mortality risk (any causes of death) assessed on the range of values measured for each vascular parameter: (A) brachial pulse pressure, (B) carotid-femoral pulse wave velocity (CF-PWV), (C) carotid pulse pressure, (D) carotid internal diameter, (E) carotid stiffness and (F) carotid intima-media thickness. P-spline curves of the Log hazard for each vascular parameter were performed on the data from the 168 patients followed at Center 1 with full dataset available. For example, considering (D), the risk of death became positive (Log hazard = 0) when Carotid internal diameter became greater or equal to 7 mm. The estimated cumulative incidence of lethal or non-lethal CV events for patients with carotid stiffness < 7 m/s (black line) was 13% versus 30% for those with carotid stiffness > 7 m/s (blue line). The estimated cumulative incidence of death unrelated to CV events (competing risk) for patients with carotid stiffness < 7 m/s (red line) was 3% versus 10% for those with carotid stiffness > 7 m/s (green line). (D) Estimated cumulative incidence of lethal or nonlethal CV events for patients with CIMT < 720 micrometers (black line) was 17% versus 24% for those with CIMT > 720 micrometers (blue line). The estimated cumulative incidence of death unrelated to CV events (competing risk) for patients with CIMT < 720 μm (red line) was 5% versus 7% for those with CIMT > 720 μm (green line). 
